Search

Sun Jae Yoo

Examiner (ID: 4021, Phone: (571)272-9074 , Office: P/1626 )

Most Active Art Unit
1626
Art Unit(s)
1622, 1609, 1626, 1621
Total Applications
1924
Issued Applications
1172
Pending Applications
219
Abandoned Applications
564

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19691161 [patent_doc_number] => 20250009706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING OPIOID DEPENDENCE AND WITHDRAWAL [patent_app_type] => utility [patent_app_number] => 18/580474 [patent_app_country] => US [patent_app_date] => 2022-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12700 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18580474 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/580474
COMPOSITIONS AND METHODS FOR TREATING OPIOID DEPENDENCE AND WITHDRAWAL Jul 17, 2022 Pending
Array ( [id] => 19265251 [patent_doc_number] => 20240208950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER [patent_app_type] => utility [patent_app_number] => 18/292049 [patent_app_country] => US [patent_app_date] => 2022-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14426 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18292049 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/292049
COMPOSITIONS AND METHODS FOR TREATMENT OF CERVICAL AND OVARIAN CANCER Jul 6, 2022 Pending
Array ( [id] => 18449401 [patent_doc_number] => 20230190677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-06-22 [patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 17/858233 [patent_app_country] => US [patent_app_date] => 2022-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7943 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858233 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/858233
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES Jul 5, 2022 Abandoned
Array ( [id] => 19990024 [patent_doc_number] => 20250128246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => MULTILAYER CATALYTIC BED FOR THE PRODUCTION OF PHTHALIC ANHYDRIDE [patent_app_type] => utility [patent_app_number] => 18/682663 [patent_app_country] => US [patent_app_date] => 2022-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3463 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682663 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/682663
MULTILAYER CATALYTIC BED FOR THE PRODUCTION OF PHTHALIC ANHYDRIDE Jul 4, 2022 Pending
Array ( [id] => 18306222 [patent_doc_number] => 20230110122 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-13 [patent_title] => COMPOUNDS AND THEIR USE [patent_app_type] => utility [patent_app_number] => 17/810367 [patent_app_country] => US [patent_app_date] => 2022-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/810367
Compounds and their use Jun 30, 2022 Issued
Array ( [id] => 18163259 [patent_doc_number] => 20230029852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-02 [patent_title] => METHOD FOR THE SYNTHESIS OF 3-R-1,4,2-DIOXAZOL-5-ONES [patent_app_type] => utility [patent_app_number] => 17/855414 [patent_app_country] => US [patent_app_date] => 2022-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6938 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17855414 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/855414
Method for the synthesis of 3-R-1,4,2-dioxazol-5-ones Jun 29, 2022 Issued
Array ( [id] => 18391317 [patent_doc_number] => 20230159535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => CDK2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/850453 [patent_app_country] => US [patent_app_date] => 2022-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45147 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17850453 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/850453
CDK2 inhibitors Jun 26, 2022 Issued
Array ( [id] => 18213434 [patent_doc_number] => 20230059698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => Method of Manufacture for Liquid Cannabinoids, and Modified CBD Oil Composition [patent_app_type] => utility [patent_app_number] => 17/845499 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4177 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845499 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/845499
Method of Manufacture for Liquid Cannabinoids, and Modified CBD Oil Composition Jun 20, 2022 Abandoned
Array ( [id] => 18109496 [patent_doc_number] => 20230002376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-05 [patent_title] => BICYCLIC PYRAZOLYL AMINES AS CDK2 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/845142 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44295 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -59 [patent_words_short_claim] => 3852 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845142 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/845142
Bicyclic pyrazolyl amines as CDK2 inhibitors Jun 20, 2022 Issued
Array ( [id] => 18221360 [patent_doc_number] => 20230060354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => DIACYLGLYERCOL KINASE MODULATING COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/845534 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 87118 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17845534 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/845534
Diacylglycerol kinase modulating compounds Jun 20, 2022 Issued
Array ( [id] => 19210685 [patent_doc_number] => 11999733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Diacylglycerol kinase modulating compounds [patent_app_type] => utility [patent_app_number] => 17/844921 [patent_app_country] => US [patent_app_date] => 2022-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69742 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17844921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/844921
Diacylglycerol kinase modulating compounds Jun 20, 2022 Issued
Array ( [id] => 20187032 [patent_doc_number] => 12398137 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-08-26 [patent_title] => Compositions providing slow release of caffeine [patent_app_type] => utility [patent_app_number] => 17/843197 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 28 [patent_no_of_words] => 8136 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843197 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/843197
Compositions providing slow release of caffeine Jun 16, 2022 Issued
Array ( [id] => 18140216 [patent_doc_number] => 20230014055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof [patent_app_type] => utility [patent_app_number] => 17/842158 [patent_app_country] => US [patent_app_date] => 2022-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31378 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842158 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/842158
Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives Thereof Jun 15, 2022 Abandoned
Array ( [id] => 19196383 [patent_doc_number] => 11993610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => BCL-2 inhibitors [patent_app_type] => utility [patent_app_number] => 17/840957 [patent_app_country] => US [patent_app_date] => 2022-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25575 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840957 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/840957
BCL-2 inhibitors Jun 14, 2022 Issued
Array ( [id] => 19394905 [patent_doc_number] => 20240284775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-22 [patent_title] => ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/289449 [patent_app_country] => US [patent_app_date] => 2022-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9974 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 446 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289449 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/289449
ORGANOMETALLIC COMPOUND AND APPLICATION THEREOF Jun 10, 2022 Pending
Array ( [id] => 19860637 [patent_doc_number] => 20250099423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4 [patent_app_type] => utility [patent_app_number] => 18/682681 [patent_app_country] => US [patent_app_date] => 2022-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15061 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682681 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/682681
PIPERAZINE-BASED AGONISTS OF LFA-1 AND VLA-4 Jun 8, 2022 Pending
Array ( [id] => 17882686 [patent_doc_number] => 20220298163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => BTK INHIBITORS WITH IMPROVED DUAL SELECTIVITY [patent_app_type] => utility [patent_app_number] => 17/828643 [patent_app_country] => US [patent_app_date] => 2022-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21041 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17828643 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/828643
BTK INHIBITORS WITH IMPROVED DUAL SELECTIVITY May 30, 2022 Abandoned
Array ( [id] => 18139339 [patent_doc_number] => 20230013175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-01-19 [patent_title] => ORAL AQUEOUS SUSPENSION FORMULATION COMPRISING CARBAMATE COMPOUND [patent_app_type] => utility [patent_app_number] => 17/826289 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6164 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17826289 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/826289
Oral aqueous suspension formulation comprising carbamate compound May 26, 2022 Issued
Array ( [id] => 19402087 [patent_doc_number] => 20240285598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-29 [patent_title] => COMPOUNDS FOR THE TREATMENT OF SARS [patent_app_type] => utility [patent_app_number] => 18/564748 [patent_app_country] => US [patent_app_date] => 2022-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14908 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18564748 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/564748
COMPOUNDS FOR THE TREATMENT OF SARS May 26, 2022 Pending
Array ( [id] => 19343702 [patent_doc_number] => 20240252665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-01 [patent_title] => CHEMICAL COUPLING LINKER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/559039 [patent_app_country] => US [patent_app_date] => 2022-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18559039 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/559039
CHEMICAL COUPLING LINKER AND USE THEREOF May 22, 2022 Pending
Menu